Answers are grounded in this paper and cite their sources.
Some somatic mutations, especially those in genes encoding tyrosine kinases, are central to the biology of specific cancers. In such instances, these “driver” mutations lead to the production of mutated enzymes, which then serendipitously serve as excellent substrates for targeted therapies.
No takes yet. Share an insight, caveat, or question.
Pao et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: